Discordances between molecular assays for rifampicin resistance in Mycobacterium tuberculosis: frequency, mechanisms and clinical impact. (2020)

First Author: Van Rie A
Attributed to:  Technology supported systems for rapid impact on TB control funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/jac/dkz564

PubMed Identifier: 32016320

Publication URI: http://europepmc.org/abstract/MED/32016320

Type: Journal Article/Review

Volume: 75

Parent Publication: The Journal of antimicrobial chemotherapy

Issue: 5

ISSN: 0305-7453